ABSTRACT
OBJECTIVE: The aim: To determine the opinion of 6th year students and interns in the specialty "General Practice - Family Medicine" on vaccination against COVID-19. PATIENTS AND METHODS: Materials and methods: We conducted an anonymous online survey of 268 sixth-year students, interns of the first and second year of study in the specialty GP/FM. Research design: 1.Creating a pilot version of the questionnaire based on a literary search. 2.Approbation and discussion of the questionnaire in the focus group. 3.Online surveys of respondents and statistical processing of the data. RESULTS: Results: The questionnaire was completed by 188 students, 48 interns in 1 year of study and 32 interns in 2 years of study. Among interns in 1st and 2nd year of study, the vaccination rate was 95.8% and 93.8%, respectively, among students - 71.3%, which is twice as much as among the general population. 30% did not receive the vaccine they considered most effective, but were vaccinated with the one that was available. CONCLUSION: Conclusions: The level of vaccination against COVID-19 in future doctors was 78.3%. The most significant reasons for refusing COVID-19 vaccination were past illness (COVID-19) - 24%, fear of vaccination - 24%, uncertainty about the effectiveness of immunoprophylaxis - 17.2%. Reasons that stimulated vaccination: the desire to protect against severe COVID-19 - 62.8%, the need to work in the medical field - 49.5%, the desire to protect others from the risks of COVID-19 infection - 38%.
Subject(s)
COVID-19 , Coronavirus , Humans , Adolescent , COVID-19 Vaccines/therapeutic use , COVID-19/prevention & control , Vaccination , Family PracticeABSTRACT
The purpose of this article is to draw attention to the treatment of respiratory diseases in the COVID-19 pandemic. In addition, we want to address the issue of vaccination, to pay attention to the incidence of disease among children. The design of this study was longitudinal. For this purpose, we use articles and studies from English-language sources, such as UpToDate, as well as peer-reviewed scientific articles from medical journals and the results of surveys of outpatient medical practitioners. There were no particular changes in the pharmacotherapy of respiratory diseases during the COVID-19 pandemic. Changes occurred in the recommendations for aerosol delivery of the drug, and it was recommended that the use of targeted therapy and the use of antileukotriene drugs for bronchial asthma with positive COVID be delayed until recovery. Covid is changing the doctor-patient communication system today, giving rise to telemedicine. He reminds us of the importance of vaccination in pandemics if it is possible, and it is already possible, and of the importance of population immunity. And also, we should not forget about the therapy of other diseases and consider the conditions of a pandemic when making treatment decisions.